Literature DB >> 11821985

Differential expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), beta actin and hypoxanthine phosphoribosyltransferase (HPRT) in postnatal rabbit sclera.

T K Moe1, J Ziliang, A Barathi, R W Beuerman.   

Abstract

PURPOSE: GAPDH, beta-actin, HPRT and 18S rRNA are constitutively expressed in all mammalian cells. In accordance with the nature of invariant control, these genes have been used to standardize genes of interest in expression studies. Recent studies have suggested that GAPDH, beta-actin and HPRT in special situations may come under temporary regulatory control, but that 18S rRNA may be more likely to remain constitutive. However, little is known about the quantitative expression of these genes in fibroblasts and in particular during early postnatal development, a time of rapid changes in cell metabolism. In this study we have examined the differential expression of these genes in association with scleral development from an early postnatal age up to young adult status.
METHODS: GAPDH, beta-actin, HPRT, and 18S rRNA gene expression were analyzed in the rabbit sclera from 1 day to 8 weeks postnatally by real-time, comparative PCR.
RESULTS: Real-time PCR analysis showed that the expression levels of GAPDH, beta-actin, and HPRT were higher in the first postnatal week and then declined. However, from 2 to 8 weeks, the mRNA levels of these three genes underwent significant variations (P < 0.01) in their levels of expression. In contrast, the expression level of 18S rRNA showed no significant variation (P >or= 0.5) over this time period. Conclusions. The present study shows that GAPDH, beta actin and HPRT gene were differentially expressed in early postnatal scleral development. It also suggests that these gene products could be implicated in the developmental process and have a crucial role in the early postnatal period. This study demonstrates that 18S rRNA may be preferable to normalize genes of interest in studies of early development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11821985     DOI: 10.1076/ceyr.23.1.44.5420

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  Tumor necrosis factor-α-induced nuclear factor-kappaB activation in human cardiomyocytes is mediated by NADPH oxidase.

Authors:  Kyaw Thu Moe; Katwadi Khairunnisa; Nwe Oo Yin; Jaye Chin-Dusting; Philip Wong; Meng Cheong Wong
Journal:  J Physiol Biochem       Date:  2014-07-25       Impact factor: 4.158

2.  Genomic and proteomic determinants of lower extremity revascularization failure: rationale and study design.

Authors:  Peter R Nelson; Kerri A O'Malley; Robert J Feezor; Lyle L Moldawer; James M Seeger
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

3.  Evaluation of gene expression profiles and pathways underlying postnatal development in mouse sclera.

Authors:  Wan'E Lim; Jia Lin Kwan; Liang Kee Goh; Roger W Beuerman; Veluchamy A Barathi
Journal:  Mol Vis       Date:  2012-06-02       Impact factor: 2.367

4.  Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells.

Authors:  K T Moe; S Aulia; F Jiang; Y L Chua; T H Koh; M C Wong; G J Dusting
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

5.  Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice.

Authors:  K T Moe; N O Yin; T M Naylynn; K Khairunnisa; M A Wutyi; Y Gu; M S M Atan; M C Wong; T H Koh; P Wong
Journal:  J Cell Mol Med       Date:  2011-12       Impact factor: 5.310

6.  Reference gene identification and validation for quantitative real-time PCR studies in developing Xenopus laevis.

Authors:  Bilal B Mughal; Michelle Leemans; Petra Spirhanzlova; Barbara Demeneix; Jean-Baptiste Fini
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

7.  Expression profiling of microarray gene signatures in acute and chronic myeloid leukaemia in human bone marrow.

Authors:  E Sakhinia; M A Estiar; S Andalib; A Rezamand
Journal:  Iran J Ped Hematol Oncol       Date:  2015-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.